Technical Data
R1595-36B
Respiratory Syncytial Virus (RSV)
|
Technical Data |
|
R1595-36B |
Respiratory Syncytial Virus (RSV) |
|
|
Description: Respiratory syncytial virus (RSV) is a negative-sense, enveloped RNA virus. The virion is variable in shape and size (average diameter of between 120 and 300nm), is unstable in the environment (surviving only a few hours on environmental surfaces) and is readily inactivated with soap and water and disinfectants. It is the most common cause of bronchiolitis and pneumonia among infants and children under 1 year of age. Illness begins most frequently with fever, runny nose, cough and sometimes wheezing. During their first RSV infection, between 25% and 40% of infants and young children have signs or symptoms of bronchiolitis or pneumonia, and 0.5% to 2% require hospitalization. Most children recover from illness in 8-15 days. The majority of children hospitalized for RSV infection are under 12 months of age. RSV also causes repeated infections throughout life, usually associated with moderate-to-severe cold-like symptoms; however, severe lower respiratory tract disease may occur at any age, especially among the elderly or among those with compromised cardiac, pulmonary, or immune systems. Applications: Suitable for use in IFA, Neutralization and ELISA. Other applications not tested. Recommended Dilutions: Optimal dilutions to be determined by the researcher. Recommended Pair: Suitable for use as the detection or conjugate (label) antibody. Matched to R1595-36 or R1595-36A as the capture or solid phase antibody. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. |
|
|||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||